Related Experiment Video
Updated: May 23, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Chronic fatigue syndrome or myalgic encephalomyelitis
1School of Nursing, Midwifery and Social Work, University of Manchester. dianne.burns@manchester.ac.uk
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|March 30, 2012
Summary
This article provides essential knowledge for healthcare professionals to recognize, assess, manage, and support patients with Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME). It emphasizes adaptable principles for CFS/ME care across various clinical settings.
Area of Science:
- Medical Science
- Immunology
- Neurology
Background:
- Chronic Fatigue Syndrome or Myalgic Encephalomyelitis (CFS/ME) is a complex, multi-system illness impacting the nervous and immune systems.
- CFS/ME affects diverse populations across all age, racial, ethnic, and socioeconomic groups.
- Effective patient management requires specialized knowledge and skills.
Purpose of the Study:
- To outline the necessary knowledge, understanding, and skills for healthcare professionals.
- To guide the recognition, assessment, management, and support of patients with CFS/ME.
- To provide adaptable principles for CFS/ME care applicable in any clinical setting.
Main Methods:
- Review of current understanding and best practices in CFS/ME care.
- Focus on essential competencies for healthcare providers.
- Emphasis on principles applicable across different healthcare environments.
Main Results:
- Identification of key knowledge areas for CFS/ME patient care.
- Definition of critical skills for assessment and management.
- Highlighting the importance of adaptable rehabilitation principles.
Conclusions:
- Healthcare professionals need specific training to effectively manage CFS/ME.
- Standardized yet flexible approaches to CFS/ME management are crucial.
- Nurses and other professionals can apply these principles universally for improved patient outcomes.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...